7 Healthcare Stocks Taking Medicine to the Next Level

Boston Scientific (BSX)

Image Credit- Google

A major focus area for Boston is interventional radiology. This is a medical specialty that performs various minimally invasive procedures using medical imaging guidance.

Globus Medical (GMED)

Image Credit- Google

Notably, Strategic Market Research states that the global spinal implants and surgery devices market size reached a valuation of $11.42 billion in 2021. By 2030, the segment could be worth over $18 billion, a CAGR of 5.23%.

iRhythm Technologies (IRTC)

Image Credit- Google

Still, recent momentum is encouraging. Also, analysts are looking at the long-term picture, rating IRTC a unanimous strong buy.

Teladoc (TDOC)

Image Credit- Google

According to Grand View Research, the global telehealth market size reached a valuation of $101.2 billion last year. Further, the segment may expand at a CAGR of 24.3% to 2030, printing annual revenue of $455.3 billion.

Moderna (MRNA)

Image Credit- Google

While shares represent a big risk given the steep losses, patient speculators may want to look into it. At the least, it has the potential to be a surprisingly robust example of healthcare stocks.

Crispr Therapeutics (CRSP)

Image Credit- Google

Sure enough, analysts did it too, pegging it a moderate buy with a $87.26 price target. That comes out to almost 35% upside potential.

Amylyx Pharmaceuticals (AMLX)

Image Credit- Google

To be fair, AMLX may be the riskiest idea on this list of advanced healthcare stocks. In the past 52 weeks, it lost more than 56% of equity value.

FOR MORE SUCH STORIES VISIT STOCKTRADERSVIDEOS